Statements (55)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:neurodegenerative_diseases
|
| gptkbp:affects |
motor neurons
|
| gptkbp:awareness_symbol |
blue infinity loop
|
| gptkbp:cause |
gptkb:unknown
|
| gptkbp:clinical_trial |
ongoing for new treatments
focus on gene therapy focus on neuroprotective agents focus on stem cell therapy focus on symptom management |
| gptkbp:color |
gptkb:blue
|
| gptkbp:community_impact |
social isolation
financial burden emotional stress caregiver fatigue |
| gptkbp:condition |
gptkb:frontotemporal_dementia
|
| gptkbp:diagnosis |
varies by type
clinical examination electromyography |
| gptkbp:environmental_concerns |
smoking
exposure to toxins |
| gptkbp:gender |
more common in men
|
| gptkbp:genetic_studies |
C9orf72 mutations
SOD1 mutations |
| gptkbp:has_research_focus |
gptkb:ALS_Therapy_Development_Institute
gptkb:ALS_Association MND Association Myotonic Dystrophy Foundation |
| https://www.w3.org/2000/01/rdf-schema#label |
Motor Neuron Disease
|
| gptkbp:is_involved_in |
online and in-person options
available for patients available for caregivers |
| gptkbp:notable_case |
gptkb:Terry_Pratchett
gptkb:Mao_Zedong gptkb:Stephen_Hawking gptkb:Lou_Gehrig gptkb:David_Niven |
| gptkbp:notable_quote |
" I have lived with the prospect of death for a long time."
" There is no cure for ALS, but there is hope." |
| gptkbp:premiered_on |
typically between 40 and 70
|
| gptkbp:prevalence |
2 per 100,000 people
|
| gptkbp:public_awareness |
gptkb:ALS_Awareness_Month
|
| gptkbp:research |
ongoing
|
| gptkbp:symptoms |
respiratory failure
difficulty speaking muscle weakness difficulty swallowing muscle atrophy |
| gptkbp:treatment |
medications
physical therapy supportive care |
| gptkbp:type_of |
gptkb:neurodegenerative_diseases
Primary Lateral Sclerosis Progressive Muscular Atrophy |
| gptkbp:bfsParent |
gptkb:The_Theory_of_Everything
|
| gptkbp:bfsLayer |
4
|